Related Experiment Videos
Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys
Abstract:
In cynomolgus monkeys, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces irreversible clinical, chemical, and pathological alterations that are similar to those found in Parkinson's disease. Unilateral carotid injections of this toxin produce ipsilateral nigrostriatal dopamine depletion while sparing the contralateral dopaminergic pathways. In order to study the damage to the nigrostriatal dopamine system in asymptomatic animals after unilateral MPTP administration, positron emission tomography (PET) scans were performed with [18F]fluoro-L-dopa (6-FD). This study demonstrates that clinically asymptomatic MPTP lesions may be assessed in vivo using 6-FD and PET.
Insights
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes Parkinson's-like damage in monkeys. Positron emission tomography (PET) with [18F]fluoro-L-dopa (6-FD) can detect this damage in animals before symptoms appear.
Area of Science:
- Neuroscience
- Toxicology
- Medical Imaging
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes Parkinson's disease-like symptoms.
- Unilateral MPTP administration in cynomolgus monkeys results in targeted nigrostriatal dopamine depletion.
Purpose of the Study:
- To investigate the utility of positron emission tomography (PET) with [18F]fluoro-L-dopa (6-FD) for detecting subclinical nigrostriatal damage.
- To assess the MPTP-induced damage in asymptomatic animals.
Main Methods:
- Cynomolgus monkeys were administered unilateral carotid injections of MPTP.
- Positron emission tomography (PET) scans were performed using [18F]fluoro-L-dopa (6-FD) to assess dopaminergic function.
Main Results:
- PET scans with 6-FD successfully identified nigrostriatal dopamine system damage in MPTP-treated monkeys.
- The imaging technique detected lesions in clinically asymptomatic animals.
Conclusions:
- PET imaging using 6-FD is a viable method for in vivo assessment of subclinical MPTP-induced neurotoxicity.
- This technique allows for the early detection of Parkinson's disease-like damage in preclinical stages.